IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
Crossref DOI link: https://doi.org/10.1007/s00262-017-1995-x
Published Online: 2017-04-11
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Melief, Sara M.
Visser, Marten
van der Burg, Sjoerd H.
Verdegaal, Els M. E.
Funding for this research was provided by:
Landsteiner Foundation for Blood Transfusion Research (1207)
KWF Kankerbestrijding (KWF UL 2012-5544)
License valid from 2017-04-11